This is one of the stocks I hold indefinitely for dividends. we're at the bottom of our current channel and a double bottom is forming in a major area of support. In my previous post I stated my accumulation sections are in the lower end of the channel, so this is prime real estate to enter. Momentum downwards has come to a halt and I believe we will retest the...
The technical figure Triangle can be found in the daily chart in the German company F. Hoffmann-La Roche AG (ROG.vx). Roche is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. Roche is the fifth largest...
JSE:APN mini rally following a positive trading statement quickly fizzled. Aspen JSE:APN reporters that EPS will be between 32% - 37%. Audited results are coming this week, the numbers are expected to remain the same. The share is trading below key levels, the stock will need great numbers to push the price up, a promising setup is the price trading above...
1) The US recession talks are rising day by day. The recession is to come, we just don't know when, but it will come. 2) Inflation is at an all-time high. The IT sector is tanking like anything. 3) The Pharma sector is known to be recession-proof and inflation-proof. People will never stop spending on medicine and healthcare, no matter how expensive it gets. 4)...
The technical figure Triangle can be found in the Belgium company Galapagos NV (GLPG.as) at daily chart. Galapagos NV (formerly known as Galapagos Genomics) is a Belgian pharmaceutical research company which was founded in 1999. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and...
GlaxoSmithKlein (GSK) just formed a Death Cross on the 1D time-frame, which is when the 1D MA50 (blue trend-line) crosses below the 1D MA200 (orange trend-line). This is technically a bearish pattern but last time it formed (March 24 2020) was exactly on the bottom of the COVID crash and the price recovered rapidly. That was of course in the aftermath of the...
Eli Lilly and Company ( NYSE:LLY ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $315.073B Current Price: $331.60 Breakout price: $334.70 Buy Zone (Top/Bottom Range): $314.00-$292.90 Price Target: $364.20-$367.50 (2nd) Estimated Duration to Target: 112-120d (2nd) Contract of Interest: $LLY 10/21/22 350c Trade price as of publish...
Novavax NVAX is actually lining up pretty well... from about 240, it tanked to 40, and on Friday, it gained 11% to close the week at 57.15. This caught my attention as it cleanly broke out of trendlines, breaking out also from a bearish divergence, on BOTH the weekly and daily chart. IMHO, it appears to be in technical and fractal alignment. Weekly chart...
NASDAQ:VRTX is on a verge of a breakout. AMEX:XPH is also staging a recovery, but still trading below key levels. For now, the focus in on a NASDAQ:VRTX look position.
The statistics are between $184 - $219(1 Year) Its Financial Health is very strong. Why not wait till Moderna makes greater progress and finds It Resistance Again at $450 Moderna has many projects running. So if we see progress in some of the projects in the next Years, we will see a great price rise. I believe it won't be difficult to reach its older...
The Statistics say between $182-$253 (1 year) This Looks like it can Happen in 1 Year. That will depend on their Progress. Let's see what will happen in 2023, but it looks ok to hold for the next 5 Years or more BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022 BioNTech is...
Merck & Company, Inc. ( NYSE:MRK ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $213.987B Current Price: $84.62 Breakout price: $91.40 Buy Zone (Top/Bottom Range): $83.60-$79.90 Price Target: $103.20-$105.80 Estimated Duration to Target: 672-696d Contract of Interest: $MRK 1/19/24 85c Trade price as of publish date: $10.17/contract
Sanofi Short Term We look to Buy at 95.00 (stop at 91.90) The medium term bias remains bullish. Levels close to the 50% pullback level of 93.25 found buyers. Previous support located at 93.08. Further upside is expected and we look to set longs in early trade. Our profit targets will be 104.35 and 110.00 Resistance: 95.16 / 98.22 / 104.35 Support: 93.25...
New York-based pharmaceutical firm SIGA Technologies (NASDAQ:SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox. Smallpox jabs vs monkeypox On May 19, the World Health...
The technical figure Pennant can be found in the US company Johnson & Johnson (JNJ) at daily chart. Johnson & Johnson is an American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list...
NSE:AUROPHARMA2! The stock has broken down and retested, therefore may undergo a correction in the short term. Trade is supported by Resistances Nearby. Risk Reward Ratio - 2:1 SL is placed above the resistance zone & the lower trendline.
The stock has broken out and retested, therefore may undergo a reversal rally. Trade is supported by Supports Nearby. Risk Reward Ratio - 2:1 SL is placed below the support zone & the lower trendline. The target is placed near resistance.
were up 15% AH and trying to consolidate if we can hold the $0.49 area and stay out of oversold stoch on the daily beating $0.545 and breaking $0.668 level stock should revisit the $0.71-$0.78 area predicting rangebound price action